The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monsonego, A.
Right arrow Articles by Weiner, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monsonego, A.
Right arrow Articles by Weiner, H. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
The Journal of Immunology, 2003, 171: 2216-2224.
Copyright © 2003 by The American Association of Immunologists

Microglia-Mediated Nitric Oxide Cytotoxicity of T Cells Following Amyloid {beta}-Peptide Presentation to Th1 Cells 1

Alon Monsonego2, Jaime Imitola, Victor Zota, Takatoku Oida and Howard L. Weiner

Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115

Alzheimer’s disease is marked by progressive accumulation of amyloid {beta}-peptide (A{beta}) which appears to trigger neurotoxic and inflammatory cascades. Substantial activation of microglia as part of a local innate immune response is prominent at sites of A{beta} plaques in the CNS. However, the role of activated microglia as A{beta} APCs and the induction of adaptive immune responses has not been investigated. We have used primary microglial cultures to characterize A{beta}-Ag presentation and interaction with A{beta}-specific T cells. We found that IFN-{gamma}-treated microglia serve as efficient A{beta} APCs of both A{beta}1–40 and A{beta}1–42, mediating CD86-dependent proliferation of A{beta}-reactive T cells. When cultured with Th1 and Th2 subsets of A{beta}-reactive T cells, Th1, but not Th2, cells, underwent apoptosis after stimulation, which was accompanied by increased levels of IFN-{gamma}, NO, and caspase-3. T cell apoptosis was prevented in the presence of an inducible NO synthase type 2 inhibitor. Microglia-mediated proliferation of A{beta}-reactive Th2 cells was associated with expression of the Th2 cytokines IL-4 and IL-10, which counterbalanced the toxic levels of NO induced by A{beta}. Our results demonstrate NO-dependent apoptosis of T cells by A{beta}-stimulated microglia which may enhance CNS innate immune responses and neurotoxicity in Alzheimer’s disease. Secretion of NO by stimulated microglia may underlie a more general pathway of T cell death in the CNS seen in neurodegenerative diseases. Furthermore, Th2 type T cell responses may have a beneficial effect on this process by down-regulation of NO and the proinflammatory environment.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Li, D.-S. Shang, W.-D. Zhao, L. Tian, B. Li, W.-G. Fang, L. Zhu, S.-M. Man, and Y.-H. Chen
Amyloid {beta} Interaction with Receptor for Advanced Glycation End Products Up-Regulates Brain Endothelial CCR5 Expression and Promotes T Cells Crossing the Blood-Brain Barrier
J. Immunol., May 1, 2009; 182(9): 5778 - 5788.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F.-D. Shi, W.-H. Piao, Y.-P. Kuo, D. I. Campagnolo, T. L. Vollmer, and R. J. Lukas
Nicotinic Attenuation of Central Nervous System Inflammation and Autoimmunity
J. Immunol., February 1, 2009; 182(3): 1730 - 1739.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Shimizu, K. Kawahara, M. Kajizono, M. Sawada, and H. Nakayama
IL-4-Induced Selective Clearance of Oligomeric {beta}-Amyloid Peptide1-42 by Rat Primary Type 2 Microglia
J. Immunol., November 1, 2008; 181(9): 6503 - 6513.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. Baron, A. Nemirovsky, I. Harpaz, H. Cohen, T. Owens, and A. Monsonego
IFN-{gamma} enhances neurogenesis in wild-type mice and in a mouse model of Alzheimer's disease
FASEB J, August 1, 2008; 22(8): 2843 - 2852.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Zhu, Y. Bando, S. Xiao, K. Yang, A. C. Anderson, V. K. Kuchroo, and S. J. Khoury
CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis
J. Immunol., October 15, 2007; 179(8): 5228 - 5237.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Bakalash, A. Rolls, O. Lider, and M. Schwartz
Chondroitin Sulfate-Derived Disaccharide Protects Retinal Cells from Elevated Intraocular Pressure in Aged and Immunocompromised Rats
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1181 - 1190.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Monsonego, J. Imitola, S. Petrovic, V. Zota, A. Nemirovsky, R. Baron, Y. Fisher, T. Owens, and H. L. Weiner
Abeta-induced meningoencephalitis is IFN-{gamma}-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease
PNAS, March 28, 2006; 103(13): 5048 - 5053.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Puzzo, O. Vitolo, F. Trinchese, J. P. Jacob, A. Palmeri, and O. Arancio
Amyloid-{beta} Peptide Inhibits Activation of the Nitric Oxide/cGMP/cAMP-Responsive Element-Binding Protein Pathway during Hippocampal Synaptic Plasticity
J. Neurosci., July 20, 2005; 25(29): 6887 - 6897.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. S. Gelinas, K. DaSilva, D. Fenili, P. St. George-Hyslop, and J. McLaurin
Immunotherapy for Alzheimer's disease
PNAS, October 5, 2004; 101(suppl_2): 14657 - 14662.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
R. B. Rock, G. Gekker, S. Hu, W. S. Sheng, M. Cheeran, J. R. Lokensgard, and P. K. Peterson
Role of Microglia in Central Nervous System Infections
Clin. Microbiol. Rev., October 1, 2004; 17(4): 942 - 964.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.